首页 | 本学科首页   官方微博 | 高级检索  
     

硼替佐米治疗多发性骨髓瘤的初步临床研究
引用本文:李彩霞,吴德沛,孙爱宁,苗瞄,刘跃均,赵晔,胡小惠,孙道平. 硼替佐米治疗多发性骨髓瘤的初步临床研究[J]. 白血病.淋巴瘤, 2006, 15(5): 349-350
作者姓名:李彩霞  吴德沛  孙爱宁  苗瞄  刘跃均  赵晔  胡小惠  孙道平
作者单位:215006,苏州,苏州大学附属第一医院血液科;215006,苏州,苏州大学附属第一医院血液科;215006,苏州,苏州大学附属第一医院血液科;215006,苏州,苏州大学附属第一医院血液科;215006,苏州,苏州大学附属第一医院血液科;215006,苏州,苏州大学附属第一医院血液科;215006,苏州,苏州大学附属第一医院血液科;215006,苏州,苏州大学附属第一医院血液科
摘    要:  目的 初步观察硼替佐米(商品名:万珂)联合化疗对多发性骨髓瘤(MM)的疗效和毒副作用。方法 5例MM患者采用万珂联合地塞米松或DVD方案治疗4个疗程,评价疗效和毒副作用。结果 3例完全缓解(CR),1例部分缓解(PR),1例达到微小反应(MR);总缓解(CR+PR)率为80 %;最常见的毒副反应为指趾麻木感、轻度白细胞和血小板减少以及肝功能异常改变。结论 万珂联合化疗治疗MM疗效好,毒副作用轻微,患者易于耐受。

关 键 词:硼替佐米  多发性骨髓瘤
文章编号:1009-9921(2006)05-0349-02
收稿时间:2006-05-11
修稿时间:2006-07-24

The primary clinical study on treatment with velcade for multiple myeloma
LI Cai-xia,WU De-pei,SUN Ai-ning,MIAO Miao,LIU Yue-jun,ZHAO Ye,HU Xiao-hui,SUN Dao-ping. The primary clinical study on treatment with velcade for multiple myeloma[J]. Journal of Leukemia & Lymphoma, 2006, 15(5): 349-350
Authors:LI Cai-xia  WU De-pei  SUN Ai-ning  MIAO Miao  LIU Yue-jun  ZHAO Ye  HU Xiao-hui  SUN Dao-ping
Affiliation:Department of Hematology, First Affiliated Hospital of Suzhou Medical University, Suzhou 215006, China
Abstract:Objective To explore the outcome and side-effects in patients with multiple myeloma treated with velcade and combined chemotherapy. Methods 5 patients with multiple myeloma were treated with the combination of velcade and dexamethasone or DVD (V-DVD regimen) chemotherapy. Results 5 patients responded to treatment. Three patients achieved complete remission (CR), 1 achieved partial remission (PR) and 1 achieved micro responded (MR). Major toxicities consisted of peripheral neuropathy, thrombocytopenia and hepatic impairment. Conclusion Velcade combined combination chemotherapy is an effective and safety treatment for patients with multiple myeloma. <
Keywords:Velcade  Multiple myeloma
本文献已被 CNKI 维普 万方数据 等数据库收录!
点击此处可从《白血病.淋巴瘤》浏览原始摘要信息
点击此处可从《白血病.淋巴瘤》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号